SEC Form D · Amendment · filed November 1, 2017
Full Genomes Corp
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (17)
Nicolas A. Taban · Stavanger, Q8DirectorPaul A. Conroy · Ridgewood, NJDirectorAbdullah A. Marafi · Kuwait City, M6DirectorJustin A. Loe · Harrisonburg, VAExec · DirectorNong A. Chen · Clarksburg, MDExec · DirectorLeon A. Kull · Yehud, L3DirectorRichard E. Foyston · Kuala Lumpur, SwitzerlandDirectorPage H. Blakely · BRYN MAWR, PAExec · DirectorThomas H. Lee · New York, NYDirectorOliver M. Slipper · New York, NYDirectorJorg H. Mohaupt · New York, NYExec · DirectorEric Levin · New York, NYDirectorStephen Cooper · New York, NYExec · DirectorCameron Strang · New York, NYDirectorAlex M. Blavatnik · New York, NYDirectorJohn Tomlin · Exeter, NHDirectorStephenson K. Green · Lodi, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗